Ophthalmology Search
Ophthalmology Ophthalmology
conjunctivitis%20-%20viral
CONJUNCTIVITIS - VIRAL
Viral conjunctivitis is the inflammation of the conjunctiva of viral etiology.
Signs and symptoms include unilateral or bilateral eye redness, foreign body sensation and follicular conjunctival reaction.
It may be caused by adenovirus, herpes simplex or molluscum contagiosum.

Introduction

  • A highly contagious acute conjunctival infection usually caused by adenovirus 
  • May be a part of a viral prodrome or is the only symptom of a viral illness 

Definition

  • Inflammation of the conjunctiva of viral etiology 

Signs and Symptoms

  • Symptoms become worse for the first 3-5 days then gradually resolve in 2-3 weeks
  • Common upper respiratory coinfection
  • Mild to moderate eye redness & pruritus
  • Watery eye discharge
  • Rare bilateral eye involvement
  • Foreign body sensation
  • Follicular conjunctival reaction
  • Common lymphadenopathy
Editor's Recommendations
Most Read Articles
Beta-blockers may reduce mortality in patients with heart failure, renal dysfunction
Roshini Claire Anthony, 6 days ago

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.
Early-life exposures affect BP in children
6 days ago
Blood pressure (BP) in children is influenced by early-life exposure to several chemicals, built environment and meteorological factors, suggests a study.
Short sleepers at higher risk of myocardial infarction
6 days ago
Short sleep duration is associated with an increased risk of myocardial infarction (MI), according to prospective observational and Mendelian randomization (MR) analyses.
Ezetimibe boosts statin effect in ACS patients with dyslipidaemia, low EPA/AA ratio
Tristan Manalac, 6 days ago
The addition of ezetimibe improves statin treatment in acute coronary syndrome (ACS) patients with dyslipidaemia and low eicosapentaenoic acid-to-arachidonic acid (EPA/AA) ratio, resulting in a lowered risk of cardiovascular events compared to monotherapy, according to a study presented at the recently concluded 2019 Congress of the European Society of Cardiology (ESC 2019) held in Paris, France.